ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase - Wikidata - awgldk - TriplyDB

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase

http://www.wikidata.org/entity/Q28505778

about

Atypical angiopoietin-like protein that regulates ANGPTL3 The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking The role of ANGPTL3 in controlling lipoprotein metabolism Genetics of lipid traits and relationship to coronary artery disease The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis Hepatic proprotein convertases modulate HDL metabolism Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism SILAC-MS Based Characterization of LPS and Resveratrol Induced Changes in Adipocyte Proteomics - Resveratrol as Ameliorating Factor on LPS Induced Changes Differential regulation and properties of angiopoietin-like proteins 3 and 4 The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice.A generalized genetic random field method for the genetic association analysis of sequencing data.Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.Genetic variation at the proprotein convertase subtilisin/kexin type 5 gene modulates high-density lipoprotein cholesterol levels PPARα in Obesity: Sex Difference and Estrogen Involvement.Regulation of the angiopoietin-like protein 3 gene by LXR.Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo.Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes Genetic determinants of plasma triglycerides Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation.Lipoprotein lipase: from gene to obesity.Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis.Updating experimental models of diabetic cardiomyopathy Determination of lipoprotein lipase activity using a novel fluorescent lipase assay.Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.New wrinkles in lipoprotein lipase biology.PPARalpha in atherosclerosis and inflammation.MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia

P2860

8a282ff84052cd5c3c99d430e7364da84201aca6 e98d8cff13594f9a9e9ee7d5f99449ff5705860d

P248

Q24303810-752EA835-FA80-4DD9-9067-97ABBE94A8A2 Q26751057-DCD12CD2-CF91-4046-A5DC-9B85A94A0601 Q26769679-64828928-A49B-4D5F-BACF-42CEEB80D5F4 Q26995252-448A7D29-7B2D-4922-86B9-6CCE3025B0C5 Q28118447-7C72E65F-99CD-4EB4-8CE8-F49CA35C9110 Q28235182-597B846F-ADDC-42CA-8260-B05B799FC58E Q28272732-7C0D2630-879D-42CE-B498-D5D5069346B0 Q28295479-2A86E948-A403-4796-9693-E68FD32B8B78 Q28504613-B5DA90BF-5395-4FEB-AE19-27AFF3B69E3C Q28504875-712BC2DF-9A84-4A8C-A928-A64686C1ED79 Q28505885-A5487F2C-9E1D-461F-B640-872F0A7E21B8 Q28508189-AC03609D-CFDD-4EB6-BDF7-B9A7AA80F6D1 Q28552746-7A1C6AA5-6AB6-4395-95A0-CB4A0FC40CB7 Q28579076-C5997004-44FC-49D7-BCFD-EAB2278C3C59 Q28579695-CB8289EF-E121-4585-90CF-E6B8A4EFC8D2 Q28589301-7CB7A296-DEA5-477E-B8F2-A3C99D076298 Q30444546-8C9DD8BB-CB6B-449E-A289-E664894E935F Q30746271-C20A2639-6E2F-40BB-83F8-CE108D35FEBA Q33569939-B9850F8C-AA53-4DEE-9D7C-834E9592CEF2 Q33608251-6A9C7E4C-42D8-48BF-9FF7-D778674CF64D Q33691116-71630C22-728E-48FC-BA89-A892C3927246 Q33741200-66EF090E-8706-4752-8AC6-99A1FAB712B2 Q33819755-358D5B7E-E12A-4A85-8C41-33F58B42FD1A Q33983247-EAED4FF5-44E8-426E-9AE3-C9C55A78070B Q34143769-A785D724-B40D-4105-BD2E-3FA3D582C251 Q34169224-8D369BD9-FC92-4757-BD5B-538D8DED6F53 Q34221134-BA8BA23D-1641-497A-AC31-6CC7ADF09F45 Q34327298-25E10BC8-CA3F-4038-8083-FECE652163AC Q34503333-A3D4E0F5-625C-43A4-9D5F-BD589BD1FB57 Q34615295-56E19CA8-B078-493A-B42E-55E261657ACF Q34706796-FD3FC211-CAF4-45B6-A648-6B282AF4681D Q34968373-9306CE07-F32F-47B6-B30F-CC96FF3D42E2 Q35131965-E25A1BA1-6C8A-4795-A32F-9B5BE983B031 Q35564129-F19D87C5-35F8-4731-94F9-75B50EE2BD4E Q35771182-F2FA3107-6AC6-4E1B-BE41-67EFC0506E1B Q35776630-96180BD8-7E22-419F-91A2-615D04090E84 Q35776636-D2AC1BB5-F1A4-42BD-9F96-5DE777108F2D Q36060371-69B56D4A-71D1-4106-9D29-166E35537CD1 Q36154953-CFD9FD37-0892-4746-B1A3-7E050A25E228 Q36315449-7E567881-D41D-4D8A-99DC-375385BE8003

P2860

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase

http://www.wikidata.org/entity/Q28505778

description

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

artículu científicu espublizáu en 2002

@ast

im September 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2002/09/13)

@sk

vědecký článek publikovaný v roce 2002

@cs

wetenschappelijk artikel (gepubliceerd op 2002/09/13)

@nl

наукова стаття, опублікована у вересні 2002

@uk

name

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@ast

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@en

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@nl

type

label

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@ast

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@en

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@nl

prefLabel

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@ast

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@en

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@nl

P1433

Q28505778-55363E70-D599-491B-B3DA-C78CEC796E45

P1476

Q28505778-B212B982-81C2-473A-94F3-5DC9641A8E41

P2093

Q28505778-2113BAEF-BD36-42DD-9EFD-74377C6D47EA

Q28505778-280ADF20-8766-4598-B2FB-CBB833CA9A3D

Q28505778-3F02FFB3-EF9C-4703-BAE5-91BDCC913850

Q28505778-4DA7CAF8-A191-4198-96A3-26C5FCF15AF0

Q28505778-5F0D35DB-2A4A-4CFB-8D40-C1D7B61EBBAA

Q28505778-86477A99-68CB-48EE-88F3-9B597CC1158C

Q28505778-A1F7CBD2-3FFC-4431-A152-A8F100C2810B

Q28505778-BF32E913-66F7-42E3-ADE5-64209C34920D

Q28505778-DE6BBBA6-5372-4E60-AB1D-228FDA3B4881

Q28505778-EA2CE956-4164-4AB6-A551-4D91EEC381BD

P2860

Q28505778-0CDD775A-01BC-4FE9-93BF-54D372333F55

Q28505778-1731722E-1A14-484C-A214-07ED95389AE9

Q28505778-29590AFE-07BA-402C-8110-5CD113DFD25B

Q28505778-30F9298D-EA91-459C-9656-9272800EB90C

Q28505778-40A0BFE6-8CBD-4F2C-A94E-226F99266E26

Q28505778-5985389A-A87E-48DC-8CC9-B4F2CFEDE1E3

Q28505778-62F11670-BEB1-4B05-BEA4-A2A6E1CE2278

Q28505778-8193B3CB-A9CA-4BAA-8942-AF477A743E8A

Q28505778-91E55007-2C02-4BDC-8F16-103B0D6AF677

Q28505778-AFBCE38E-E445-437C-A2A3-27D4C3FC6ED6

P304

Q28505778-BE8F4589-7CDC-4538-8655-2C5C6D98544F

P31

Q28505778-606ECD8B-DF35-4FA1-8DE8-796210D7274D

P3181

Q28505778-27587D69-9393-4D7E-82B2-6E14EA78429C

P356

Q28505778-FEECC607-A6DD-4AF9-9909-2501CB0F528E

P407

Q28505778-8C7A18CD-0606-4498-B0AE-3206477485DC

P433

Q28505778-37193F63-1A0D-430C-A844-A4E88E1DDC82

P478

Q28505778-1012E92E-C324-4847-A11A-A62BD11A04CD

P577

Q28505778-CE942BAE-26A1-488A-AECA-92E5457B2986

P698

Q28505778-0892DD41-1F2B-4485-9574-F3391A190FE0

P921

Q28505778-36483580-0EDD-4FC1-808E-F1FDCA73121E

Q28505778-CA1E7487-82DA-4C8C-AC45-3757701B643A

P3181

P356

P1433

Journal of Biological Chemistry

P1476

ANGPTL3 decreases very low den ...... hibition of lipoprotein lipase

@en

P2093

Hidehiko Furukawa

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Minekura

http://www.w3.org/2001/XMLSchema#string

Kenichi Yoshida

http://www.w3.org/2001/XMLSchema#string

Kenjiro Ueda

http://www.w3.org/2001/XMLSchema#string

Mitsuru Ono

http://www.w3.org/2001/XMLSchema#string

Mitsuru Shimamura

http://www.w3.org/2001/XMLSchema#string

Ryuta Koishi

http://www.w3.org/2001/XMLSchema#string

Takafumi Kohama

http://www.w3.org/2001/XMLSchema#string

Tetsuya Shimizugawa

http://www.w3.org/2001/XMLSchema#string

Toshimori Inaba

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietins 3 and 4: diverging gene counterparts in mice and humans

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity

Angptl3 regulates lipid metabolism in mice

Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome.

Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice

Genetic factors in lipoprotein metabolism. Analysis of a genetic cross between inbred mouse strains NZB/BINJ and SM/J using a complete linkage map approach.

P304

33742–33748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

845613

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M203215200

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12097324

http://www.w3.org/2001/XMLSchema#string

P921